Erlonat 150 mg Tablet belongs to the group of medicine called ‘anti-cancer’ primarily used for lung and pancreatic cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. In this disease, cells of the lung grow uncontrollably, and if not detected at an early stage may spread to other body parts, including the brain. Pancreatic cancer is an uncontrolled cancerous growth in the pancreas, usually in the cells that produce insulin.

Erlonat 150 mg Tablet contains 'Erlotinib' that belongs to the group of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it prevents the spread of cancerous cells.

Take Erlonat 150 mg Tablet as prescribed by your doctor. You are suggested to take Erlonat 150 mg Tablet as long as your doctor has prescribed it after checking your medical condition.  In some cases, you may experience certain common side-effects such as abdominal pain, bone pain, breathlessness, constipation, cough, diarrhea, edema (swelling), fatigue, fever, infection, muscle pain, nausea, rash, stomatitis (inflammation of the mouth), vomiting, weight loss abnormal blood tests for the liver function. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.

To treat your condition effectually, continue taking Erlonat 150 mg Tablet for as long as your doctor has prescribed. Do not take Erlonat 150 mg Tablet if you are pregnant or planning for pregnancy and breastfeeding as Erlonat 150 mg Tablet causes serious congenital disabilities. Older adults are more sensitive to medicine so that they may adjust the dosage according to the condition. While taking Erlonat 150 mg Tablet , you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF). Regular blood tests are required to monitor liver function and blood cells in the blood while taking Erlonat 150 mg Tablet . Avoid consuming alcohol along with Erlonat 150 mg Tablet as it could lead to increased dizziness.

Erlonat 150 mg Tablet is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Erlonat 150 mg Tablet travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Erlonat 150 mg Tablet contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Erlonat 150 mg Tablet targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Erlonat 150 mg Tablet stops the production, spread, and growth of cancerous cells in the body. 

Do not take Erlonat 150 mg Tablet if you are allergic to Erlonat 150 mg Tablet or any of its ingredients. While taking Erlonat 150 mg Tablet , you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF) while going out as it can lead to a skin rash if you are not using a strong SPF. Erlonat 150 mg Tablet can cause leg swelling and water retention or fluid overload (edema), so if you have unexpected rapid weight gain, please consult your doctor. Do not take Erlonat 150 mg Tablet if you are pregnant or planning to get pregnant and breastfeeding as it could harm the unborn baby. Use effective birth control measures while taking this medication and for at least 1 month after your last dose. Erlonat 150 mg Tablet is not recommended for children and adolescents. You are advised to stop smoking while taking Erlonat 150 mg Tablet as smoking could decrease this medication's effect. Erlonat 150 mg Tablet may make you more susceptible to infections, consult your doctor if you develop any signs of infections, fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising.  Erlonat 150 mg Tablet may cause blurry vision and dizziness, so do not drive or operate any machinery which requires concentration. Before undergoing any surgery, it is advised to tell the medical professional who performs the procedure about all the medicines you are taking.